. 2021 Sep 30;11:19429. doi: 10.1038/s41598-021-98582-9

Table 2.

Details of the experimental design.

Treatment number (s)	Treatments	Treatments details	Symbols
1	Control group	No exposure to stressors (arsenic + temperature and no supplementation of Se-NPs and EPA + DHA) and fed with control diet	Control
2	Arsenic (2.68 mg L⁻¹) and high temperature (34 °C) exposure	Concurrent exposure to arsenic (2.68 mg L⁻¹) and high temperature (34 °C) and fed with control diet	As + T
3	Se-NPs at 0.2 mg kg⁻¹ diet with EPA + DHA at 0.2%	Fed with Se-NPs at 0.2 mg kg⁻¹ and mixture of EPA + DHA at 0.2%	Se-NPs + ED-0.2%
4	Se-NPs at 0.2 mg kg⁻¹ diet with EPA + DHA at 0.4%	Fed with Se-NPs at 0.2 mg kg⁻¹ and mixture of EPA + DHA at 0.4%	Se-NPs + ED-0.4%
5	Se-NPs at 0.2 mg kg⁻¹ diet with EPA + DHA at 0.6%	Fed with Se-NPs at 0.2 mg kg⁻¹ and mixture of EPA + DHA at 0.6%	Se-NPs + ED-0.6%
6	Fed with Se-NPs at 0.2 mg kg⁻¹ diet with EPA + DHA at 0.2% and concurrent exposure to arsenic and high temperature	Fed with Se-NPs at 0.2 mg kg⁻¹ and mixture of EPA + DHA at 0.2% and treated under concurrent exposure to arsenic 2.68 mg L⁻¹) and high temperature (34 °C)	Se-NPs + ED-0.2%
7	Fed with Se-NPs at 0.2 mg kg⁻¹ diet with EPA + DHA at 0.4% and concurrent exposure to arsenic and high temperature	Fed with Se-NPs at 0.2 mg kg⁻¹ and mixture of EPA + DHA at 0.4% and treated under concurrent exposure to arsenic 2.68 mg L⁻¹) and high temperature (34 °C)	Se-NPs + ED-0.4%
8	Fed with Se-NPs at 0.2 mg kg⁻¹ diet with EPA + DHA at 0.6% and concurrent exposure to arsenic and high temperature	Fed with Se-NPs at 0.2 mg kg⁻¹ and mixture of EPA + DHA at 0.6% and treated under concurrent exposure to arsenic 2.68 mg L⁻¹) and high temperature (34 °C)	Se-NPs + ED-0.6%